Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in Black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in Black patients.
Our panel of expert Hematology/Oncology faculty convene a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among Black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center.
This educational program builds off the complementary enduring activity to further address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM. This activity dives into the results of the focus groups via a moderated panel discussion of the interprofessional care team.
|
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in black patients.
Our panel of expert Hematology/Oncology faculty convened a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center.
The goals of our educational program are to address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM.
|
Learn about Prenatal Alcohol Exposure, Fetal Alcohol Spectrum Disorders (FASDs), and how to talk to your patients about unhealthy alcohol use.This 3-part podcast features interviews with
|
There is no charge to take this program. Please click on the red button above to register. You may be asked to create an account before you register.
|
♦ NOTE: This course
|
This course includes a recording of the live session on 01/26/2022.
|
What is the school enrollment process for refugee students? How do school nurses obtain necessary health records and support the health needs of incoming refugee students?
|
NOTE: This is the RECORDING of the Zoom
|
What key competencies are necessary to be a strong performing leader? What steps can I take to build these skills?
|
Do you feel confident in your ability to recognize and respond to trauma experienced by your students? Are you aware of the tendency to misinterpret trauma-related behaviors in Black, Indigenou
|